Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
<p>Figure S2. Lurbinectedin sensitivity (IC50) correlation with MYC expression and changes in expression of NE markers.</p>
Saved in:
| 主要作者: | Subhamoy Chakraborty (16648124) (author) |
|---|---|
| 其他作者: | Charles Coleman (16648127) (author), Parvathy Manoj (16648130) (author), Deniz Demircioglu (15306139) (author), Nisargbhai Shah (16648133) (author), Elisa de Stanchina (14954757) (author), Charles M. Rudin (11572933) (author), Dan Hasson (15306151) (author), Triparna Sen (14126577) (author) |
| 出版: |
2025
|
| 主題: | |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
由: Subhamoy Chakraborty (16648124)
出版: (2025) -
Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
由: Subhamoy Chakraborty (16648124)
出版: (2025) -
Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
由: Subhamoy Chakraborty (16648124)
出版: (2025) -
Filamin A KO and S2152A KI reduce KSHV de novo infection of cell-free virions.
由: Xiaojuan Li (351842)
出版: (2025) -
Filamin A KO and S2152A KI reduce KSHV de novo infection and cell-contact mediated viral infection.
由: Xiaojuan Li (351842)
出版: (2025)